Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne

Dermatology. 1999;198(2):218-22. doi: 10.1159/000018117.

Abstract

Background: Adapalene and tretinoin are topical compounds active for treating acne.

Objective: To compare the efficacity and safety of adapalene 0.1% gel and tretinoin 0.05% gel in moderately severe facial acne using clinical and objective biometrological assessments. Such information is currently lacking in the literature.

Methods: The split-face method was used in 25 acne volunteers for a 6-week treatment. In addition to clinical counts of lesions, the amount of comedones was assessed using computer-assisted morphometry of cyanoacrylate follicular biopsies. The erythema index and squamometry values were used to quantitate skin irritation.

Results: The tretinoin formulation brought better comedolysis and clinical improvement than the adapalene formulation. Erythema was transiently more pronounced on the tretinoin-treated side. Squamometry yielded no significant difference between both products.

Conclusion: Tretinoin 0.05% gel exhibits a greater anti-acne efficacy than adapalene 0.1% gel, although with temperate tolerability.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Acne Vulgaris / drug therapy*
  • Acne Vulgaris / pathology
  • Adapalene
  • Administration, Topical
  • Adult
  • Dermatologic Agents / administration & dosage*
  • Dermatologic Agents / adverse effects
  • Facial Dermatoses / drug therapy*
  • Facial Dermatoses / pathology
  • Humans
  • Keratolytic Agents / administration & dosage*
  • Keratolytic Agents / adverse effects
  • Male
  • Naphthalenes / administration & dosage*
  • Naphthalenes / adverse effects
  • Single-Blind Method
  • Skin / pathology
  • Tretinoin / administration & dosage*
  • Tretinoin / adverse effects

Substances

  • Dermatologic Agents
  • Keratolytic Agents
  • Naphthalenes
  • Adapalene
  • Tretinoin